The toxic effect of small iodine supplements in patients with autonomous thyroid nodules
- PMID: 890996
- DOI: 10.1111/j.1365-2265.1977.tb01303.x
The toxic effect of small iodine supplements in patients with autonomous thyroid nodules
Abstract
In sixteen cases of toxic adenoma of the thyroid (autonomous hot nodule with complete suppression of the surrounding normal parenchyma) potassium iodide was given in doses of 100 microgram/day for one week, 200 microgram/day for another and 400 microgram/day for a third week. There was a progressive increase in the serum T4 level. Serum T3 also increased, although this was significant only after the first week. Serum TSH was undetectable throughout the entire period of the study. This metabolic pattern is different from the response seen in cases of nontoxic endemic goitre, where small iodine supplements induce an increase in serum T4 but a decrease in serum T3. Furthermore, the present results may explain the phenomenon of iodine-induced or iodine-precipitated hyperthyroidism (Jod-Basedow) when patients with autonomous thyroid are presented with a high iodine intake. In contrast to the results obtained with small iodide doses, two other cases treated with large pharmacological doses of iodide showed a decrease in both serum T4 and serum T3. It is concluded that the physician should be aware of the possibility of precipitating or aggravating thyrotoxicosis in patients with an autonomous hot nodule by increasing their intake of iodine.
Similar articles
-
The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.Thyroid. 2008 Jun;18(6):641-5. doi: 10.1089/thy.2007.0348. Thyroid. 2008. PMID: 18578614
-
Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.J Clin Endocrinol Metab. 1977 Jul;45(1):25-9. doi: 10.1210/jcem-45-1-25. J Clin Endocrinol Metab. 1977. PMID: 577497
-
Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.Clin Endocrinol (Oxf). 1993 Jul;39(1):67-71. doi: 10.1111/j.1365-2265.1993.tb01752.x. Clin Endocrinol (Oxf). 1993. PMID: 8348708
-
The medical treatment of non-toxic goiter: several questions remain.Thyroidology. 1993 Aug;5(2):49-55. Thyroidology. 1993. PMID: 7522531 Review.
-
TSH secretion and regulation in endemic goiter and endemic cretinism.Prog Clin Biol Res. 1983;116:119-30. Prog Clin Biol Res. 1983. PMID: 6304776 Review.
Cited by
-
Iodine contamination as a cause of hyperthyroidism or lack of TSH response to TRH stimulation (results based on a screening investigation).J Endocrinol Invest. 1982 May-Jun;5(3):153-6. doi: 10.1007/BF03349470. J Endocrinol Invest. 1982. PMID: 6809805
-
Safety and efficacy of prophylactic treatment for hyperthyroidism induced by iodinated contrast media in a high-risk population.Front Endocrinol (Lausanne). 2023 May 15;14:1154251. doi: 10.3389/fendo.2023.1154251. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37255974 Free PMC article.
-
[Operative indications and surgical procedure in iodine-induced hyperthyroidism].Langenbecks Arch Chir. 1985;365(2):79-89. doi: 10.1007/BF01261135. Langenbecks Arch Chir. 1985. PMID: 4046686 German.
-
Failure to reach euthyroidism with potassium iodide and propranolol in preparation of patient with Graves' disease for surgery.J Endocrinol Invest. 1981 Jul-Sep;4(3):367-8. doi: 10.1007/BF03349459. J Endocrinol Invest. 1981. PMID: 6895641 No abstract available.
-
Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy.Endocrine. 2011 Dec;40(3):344-53. doi: 10.1007/s12020-011-9542-6. Epub 2011 Oct 5. Endocrine. 2011. PMID: 21971931 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources